Omada Health is leading the field of digital therapeutics by creating innovative, scalable, and cost-effective online behavior-change programs that address the growing epidemic of chronic disease.

Our flagship product Prevent is based on guidelines published by the CDC's National Diabetes Prevention Program (NDPP), and has been shown in a clinical trial to help people lose weight and positively impact the risk factors that contribute to type 2 diabetes and heart disease.

Omada was named by Fast Company as one of the world's top 50 most innovative companies of 2015.

It was founded in 2011 and is currently headquartered in San Francisco, CA.

^[1]